Le Lézard
Classified in: Health, Science and technology, Business
Subject: AWD

DOMINION DIAGNOSTICS Earns 2024 Great Place To Work Certificationtm


NORTH KINGSTOWN, R.I., March 12, 2024 /PRNewswire/ -- Dominion Diagnostics, a leading national medical laboratory specializing in urine drug monitoring solutions is proud to announce that it has been Certifiedtm by Great Place To Work® in 2024.

Dominion Diagnostics is proud to announce that it has been Certifiedtm by Great Place To Work® in 2024.

With 90% of employees affirming that it's a great place to work, Dominion Diagnostics stands 33 points above the average U.S. company.

Great Place To Work® is the global authority on workplace culture, Certification and official recognition are earned through real-time feedback of employees on company culture by measuring the level of trust in their organization and the consistency of the employee experience.

"Achieving the Great Place to Work® certification is a tremendous honor for us. It reflects our unwavering dedication to our team's growth and well-being, and I couldn't be more proud of the culture we've built together. This certification affirms our belief that a supportive, engaging, and collaborative workplace leads to innovative solutions for the challenges we face in healthcare."
? Bob Garvey, CEO of Dominion Diagnostics

The Great Place to Work Certificationtm is based on results of the Trust Indextm survey administered by the Great Place to Work Institute, and it underscores Dominion Diagnostics' dedication to transparency, fairness, and respect across all levels. A summary of the scores can be found on the Dominion Diagnostics Certified Company Profile, with expanded highlights including:

Looking to grow your career at a company that puts its people first? You can learn more about Dominion Diagnostics' people, culture and career opportunities at DominionDiagnostics.com or search job current openings on their Careers page.

About Dominion Diagnostics

Dominion Diagnostics is a leading, certified, and accredited national medical laboratory that provides urine drug monitoring solutions and actionable clinical information to improve patient care and treatment outcomes in the treatment of Substance Use Disorder and chronic Pain Management.

Dominion Diagnostics helps healthcare providers make better informed treatment decisions and improve patient outcomes through responsible, medically necessary monitoring programs. Entrusted by customers across the United States, Dominion Diagnostics understands unique patient needs, support practice regulatory compliance, and is committed to improving healthcare through trusted diagnostics and actionable clinical information.

Over the last ten years, Dominion Diagnostics has consistently been honored for its commitment to employee welfare and excellence. This includes being recognized seven times as one of the Best Places to Work in Rhode Island by Providence Business News and Best Companies Group, as well as receiving the Worksite Health Award from Blue Cross & Blue Shield of Rhode Island for nine straight years. These awards commend Dominion's exceptional health and wellness programs, underscoring its leadership in fostering a healthy and vibrant workplace culture.

Learn more at DominionDiagnostics.com or on LinkedIn, Facebook, Twitter/X, and YouTube.

For media inquiries, contact - Hilary Hoopes, Director of Marketing & Sales Training |
[email protected] | 401.667.5607

SOURCE Dominion Diagnostics


These press releases may also interest you

at 19:28
BTQ Technologies Corp. (the "Company") (CBOE CA: BTQ) is providing this bi-weekly update on the status of the management cease trade order issued on April 3, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission...

at 19:24
DeFi Technologies Inc. (the "Company" or "DEFI") (CBOE CA: DEFI) (GR: R9B) , a financial technology company and the first and only publicly traded company that bridges the gap between traditional capital markets, Web3 and decentralised finance,today...

at 19:16
The global graphene market  size is estimated to grow by USD 773.01 mn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of  34.07%  during the forecast period. ...

at 19:13
David Sugden, trial specialist and shareholder at Call & Jensen, obtained a $6.7 million verdict for Ten-X, in a high-profile case involving breach of contract and fraud. The case centered around Ten-X, an online platform that facilitates commercial...

at 19:12
NASA was named Thursday as the 2023 Best Place to Work in the Federal Government ? large agency ? for the 12th year in a row by the Partnership for Public Service. The title serves as a reflection of employee satisfaction with the workplace and...

at 18:46
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...



News published on and distributed by: